Comparison of recurrence patterns between ≤5 years and >5 years after curative operations in colorectal cancer patients

Journal of Surgical Oncology

Volumn 108, Issue 1, 2013, Pages 9-13

  Seo, Seok In ^a   Lim, Seok Byung ^a   Yoon, Yong Sik ^a   Kim, Chan Wook ^a   Yu, Chang Sik ^a   Kim, Tae Won ^a   Kim, Jong Hoon ^a   Kim, Jin Cheon ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

colorectal cancer; early; late; patterns; recurrence

Indexed keywords

CAPECITABINE; CARCINOEMBRYONIC ANTIGEN; DOXIFLURIDINE; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; OXALIPLATIN; TEGAFUR;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CANCER GROWTH; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CELL DIFFERENTIATION; COLORECTAL CANCER; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; LIVER METASTASIS; LUNG METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RECTUM CANCER; THORAX RADIOGRAPHY;

ADENOCARCINOMA; CARCINOEMBRYONIC ANTIGEN; CHEMOTHERAPY, ADJUVANT; COLONIC NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; LIVER NEOPLASMS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RADIOTHERAPY, ADJUVANT; RECTAL NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84879412347     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.23349     Document Type: Article

References (30)

1. Heald RJ, Ryall RD:, Recurrence and survival after total mesorectal excision for rectal cancer. Lancet 1986; 1: 1479-1482.
2. Obrand DI, Gordon PH:, Incidence and patterns of recurrence following curative resection for colorectal carcinoma. Dis Colon Rectum 1997; 40: 15-24.
3. Tjandra JJ, Chan MK:, Follow-up after curative resection of colorectal cancer: A meta-analysis. Dis Colon Rectum 2007; 50: 1783-1799.
4. Böhm B, Schwenk W, Hucke H, et al.: Does methodic long-term follow-up affect survival after curative resection of colorectal carcinoma ? Dis Colon Rectum 1993; 36: 280-286.
5. Figueredo A, Rumble RB, Maroun J, et al.: Follow-up of patients with curatively resected colorectal cancer: A practice guideline. BMC Cancer 2003; 3: 26.
6. Kapiteijn E, Marijnen CA, Nagtegaal ID, et al.: Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 2001; 345: 638-646.
7. Cho YB, Chun HK, Yun HR, et al.: Clinical and pathologic evaluation of patients with recurrence of colorectal cancer five or more years after curative resection. Dis Colon Rectum 2007; 50: 1204-1210.
8. Umpleby HC, Bristol JB, Rainey JB, et al.: Survival of 727 patients with single carcinomas of the large bowel. Dis Colon Rectum 1984; 27: 803-810.
9. Sadahiro S, Suzuki T, Ishikawa K, et al.: Recurrence patterns after curative resection of colorectal cancer in patients followed for a minimum of ten years. Hepatogastroenterology 2003; 50: 1362-1366.
10. Kjeldsen BJ, Kronborg O, Fenger C, et al.: The pattern of recurrent colorectal cancer in a prospective randomised study and the characteristics of diagnostic tests. Int J Colorectal Dis 1997; 12: 329-334.
11. Willett CG, Tepper JE, Cohen AM, et al.: Failure patterns following curative resection of colonic carcinoma. Ann Surg 1984; 200: 685-690.
12. Schildberg FW, Lange V, Thies E, et al.: Therapy of recurrent colorectal cancers. Chirurg 1985; 56: 509-514.
13. Eisenberg B, Decosse JJ, Harford F, et al.: Carcinoma of the colon and rectum: The natural history reviewed in 1704 patients. Cancer 1982; 49: 1131-1134.
14. Carriquiry LA, Pineyro A:, Should carcinoembryonic antigen be used in the management of patients with colorectal cancer ? Dis Colon Rectum 1999; 42: 921-929.
15. Harrison LE, Guillem JG, Paty P, et al.: Preoperative carcinoembryonic antigen predicts outcomes in node-negative colon cancer patients: A multivariate analysis of 572 patients. J Am Coll Surg 1997; 185: 55-59.
16. Chu DZ, Erickson CA, Russell MP, et al.: Prognostic significance of carcinoembryonic antigen in colorectal carcinoma. Serum levels before and after resection and before recurrence. Arch Surg 1991; 126: 314-316.
17. Blake KE, Dalbow MH, Concannon JP, et al.: Clinical significance of the preoperative plasma carcinoembryonic antigen (CEA) level in patients with carcinoma of the large bowel. Dis Colon Rectum 1982; 25: 24-32.
18. Zlobec I, Lugli A:, Prognostic and predictive factors in colorectal cancer. Postgrad Med J 2008; 84: 403-411.
19. Morikawa T, Kuchiba A, Qian ZR, et al.: Prognostic significance and molecular associations of tumor growth pattern in colorectal cancer. Ann Surg Oncol 2012; 19: 1944-1953.
20. Jass JR, Love SB, Northover JM:, A new prognostic classification of rectal cancer. Lancet 1987; 1: 1303-1306.
21. Kubota Y, Petras RE, Easley KA, et al.: Ki-67-determined growth fraction versus standard staging and grading parameters in colorectal carcinoma. A multivariate analysis. Cancer 1992; 70: 2602-2609.
22. Zlobec I, Baker K, Minoo P, et al.: Tumor border configuration added to TNM staging better stratifies stage II colorectal cancer patients into prognostic subgroups. Cancer 2009; 115: 4021-4029.
23. Talbot IC, Ritchie S, Leighton MH, et al.: The clinical significance of invasion of veins by rectal cancer. Br J Surg 1980; 67: 439-442.
24. Gatta G, Faivre J, Capocaccia R, et al.: Survival of colorectal cancer patients in Europe during the period 1978-1989. Eur J Cancer 1998; 34: 2176-2183.
25. Lemmens V, van Steenbergen L, Janssen-Heijnen M, et al.: Trends in colorectal cancer in the south of the Netherlands 1975-2007: Rectal cancer survival levels with colon cancer survival. Acta Oncol 2010; 49: 784-796.
26. Heald RJ, Moran BJ, Ryall RD, et al.: Rectal cancer: The Basingstoke experience of total mesorectal excision, 1978-1997. Arch Surg 1998; 133: 894-899.
27. Wolmark N, Rockette H, Fisher B, et al.: The benefit of leucovorin-modulated fluorouracil as postoperative adjuvant therapy for primary colon cancer: results from National Surgical Adjuvant Breast and Bowel Project protocol C-03. J Clin Oncol 1993; 11: 1879-1887.
28. Fisher B, Wolmark N, Rockette H, et al.: Postoperative adjuvant chemotherapy or radiation therapy for rectal cancer: Results from NSABP protocol R-011. J Natl Cancer Inst 1988; 80: 21-29.
29. Weiss L, Grundmann E, Torhorst J, et al.: Haematogenous metastatic patterns in colonic carcinoma: An analysis of 1541 necropsies. J Pathol 1986; 150: 195-203.
30. MacMahon H, Austin JH, Gamsu G, et al.: Guidelines for management of small pulmonary nodules detected on CT scans: A statement from the Fleischner society. Radiology 2005; 237: 395-400. Therapeutics